Retatrutide
Retatrutide — GLP-1/GIP/Glucagon Triple Agonist
A synthetic triple receptor agonist investigated in preclinical research for its activity at GLP-1, GIP, and glucagon receptors simultaneously. Retatrutide is among the most studied next-generation metabolic research compounds in current literature, with published data examining receptor binding kinetics, downstream signaling cascades, and energy homeostasis mechanisms at the cellular level.
LY3437943 is a triagonist peptide activating GLP-1, GIP, and glucagon receptors in concert. Preclinical data examines comparative receptor engagement versus dual agonists in adipose tissue models, hepatic lipid clearance pathways, and glucose-insulin axis signaling. Its extended half-life profile is conferred by a C20 fatty acid conjugate enabling extended dosing interval paradigms in research models.
- Scientific Name
- Retatrutide — GLP-1/GIP/Glucagon Triple Agonist
- CAS Number
- 2381089-83-2
- Molecular Formula
- C₂₂₁H₃₄₂N₄₆O₆₈
- Molecular Weight
- 4,731.33 g/mol
- Physical Form
- Lyophilized powder
- Purity
- 99%+
- Batch Number
- 42565
- Storage
- −20°C, avoid repeated freeze-thaw cycles
◇ Research Use Only
This product is supplied as a high-purity research compound for in-vitro laboratory use only. Not for human or animal consumption. Not evaluated or approved by the FDA.
Independently tested for purity, weight, heavy metals, and endotoxins. Every batch ships with a Certificate of Analysis.